Provided by Tiger Trade Technology Pte. Ltd.

YieldMax MRNA Option Income Strategy ETF

33.25
+0.63001.93%
Pre-market: 33.250.00000.00%05:00 EDT
Volume:284.01K
Turnover:9.36M
Market Cap:134.83M
PE:- -
High:33.75
Open:32.00
Low:31.66
Close:32.62
52wk High:42.39
52wk Low:13.60
Shares:4.05M
Float Shares:4.05M
Volume Ratio:1.10
T/O Rate:7.00%
Dividend:15.23
Dividend Rate:45.81%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Moderna extends rally, shares up 89% to $118.99 after melonoma data

TIPRANKS
·
Aug 19

Moderna upgraded to Outperform from Market Perform at William Blair

TIPRANKS
·
Aug 19

Biotech Stocks Jump Premarket After Moderna's Melanoma Vaccine with Merck Succeeds in Large Trial

THOMSON REUTERS
·
Aug 19

The Bond Selloff is Rattling Investors, but Here's Why They Shouldn't Expect a Deeper Stock Downturn

Dow Jones
·
Aug 19

The "Holy Grail" Of Cancer Treatment? Moderna's Melanoma MRNA Vaccine Succeeds In Phase 3 Trial

Options & Short Sell
·
Aug 19

Moderna Shares More than Double Premarket; Last up 103%

THOMSON REUTERS
·
Aug 19

Stocks to Watch: Oracle, SK Hynix, Moderna, Unitree

Dow Jones
·
Aug 19

US Stocks-Wall St Futures Flat After Tech Rout; Iran Tensions, Retail Earnings in Focus

Reuters
·
Aug 19

Moderna, Merck, La-Z-Boy, SK Hynix, and More Stocks That Explain Today's Market

Dow Jones
·
Aug 19

U.S. Stocks on the MOVE-Estee Lauder, Target, Analog Devices

Reuters
·
Aug 19

Merck, Moderna Say Potential Melanoma Therapy Shows 'Statistically Significant Improvement' in Late-Stage Trial

MT Newswires Live
·
Aug 19

Bond Yields, Persian Gulf Outlooks Cap Wall Street Pre-Bell; Asia, Europe Off

MT Newswires Live
·
Aug 19

Moderna Stock Surges 70%, Merck Rises 6%. at Last, a Successful Cancer Vaccine.

Dow Jones
·
Aug 19

Moderna and Merck Say Melanoma Skin Cancer Vaccine Meets Goals in Large Trial

Reuters
·
Aug 19

Moderna Vaccine Cuts Recurrence and Spread of High-Risk Melanoma, Raising New Treatment Hope

Reuters
·
Aug 19

Moderna jumps 54% to $97.52 after Phase 3 INTerpath-001 trial met endpoints

TIPRANKS
·
Aug 19

Moderna Shares Extend Gains; Last up 46.9% Premarket

THOMSON REUTERS
·
Aug 19

Merck, Moderna Say Melanoma Skin Cancer Vaccine Meets Goals in Large Trial

Reuters
·
Aug 19

Merck: Co, Moderna Announce Positive Results from Phase 3 Interpath-001 Trial for Patients with Completely Resected Stage Iib-Iv Melanoma

THOMSON REUTERS
·
Aug 19

Merck: Co, Moderna Will Engage with Regulators on Filing Submissions for Intismeran Autogene in Combination with Keytruda

THOMSON REUTERS
·
Aug 19